Home › Ulcerative Colitis › Texas › Tyler
Pag-aaral pangklinika para sa Ulcerative Colitis sa Tyler, TX
14 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Tyler (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Site US-004, Tyler
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- Xencor Investigative Site, Tyler
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Tyler Research Institute, LLC, Tyler
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Tyler Research Institute, Tyler
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Tyler Research Institute, Tyler
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Nagre-recruitPhase 2
- Tyler Research Institute, Tyler
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Nagre-recruitPhase 4
- Tyler Research Institute, LLC, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Nagre-recruitPhase 3
- Tyler Research Institute ( Site 0294), Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Tyler Research Institute, LLC, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Tyler Research Institute, LLC - Site Number: 8400095, Tyler
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Tyler Research Institute, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Nagre-recruitPhase 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Tyler
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- New York City, NY24 pag-aaral
- Orlando, FL23 pag-aaral
- Miami, FL22 pag-aaral
- Houston, TX18 pag-aaral
- San Antonio, TX16 pag-aaral
- San Diego, CA16 pag-aaral
- Tacoma, WA15 pag-aaral
- Chicago, IL15 pag-aaral
- St. Louis, MO14 pag-aaral
- Colorado Springs, CO14 pag-aaral
- Los Angeles, CA13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Tyler
- Non-Small Cell Lung Cancer20 pag-aaral
- Crohn's Disease16 pag-aaral
- Pagkabigo ng Puso8 pag-aaral
- Colorectal Cancer8 pag-aaral
- Kanser sa Ovary7 pag-aaral
- Kanser (lahat ng uri)7 pag-aaral
- Kanser ng Endometrium6 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Kanser sa Suso6 pag-aaral
- Chronic Lymphocytic Leukemia5 pag-aaral
- Small Cell Lung Cancer5 pag-aaral
- Metastatic Cancer5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.